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Abstract: OBJECTIVES: In newborn rodents, intestinal maturation involves delayed fructose transporter
GLUT5 expression until weaning. In jejunoileal atresia (JIA), distal intestinal segments lack exposure
to amniotic fluid-containing carbohydrates. We assessed in human newborns, the impact of intestinal
maturation and obstruction on mucosal monosaccharide transporter expression. METHODS: Samples
were obtained from 10 newborns operated for small intestinal atresia and from 17 adults undergoing
gastroduodenoscopy and/or ileocolonoscopy. mRNA expression of the transporters SGLT1, GLUT1,
GLUT2, GLUT5, and GLUT7 was measured in neonate samples proximal and distal of the atresia as
well as in adult duodenum, ileum, and colon. Protein expression and localization was assessed using
immunofluorescence. RESULTS: Although mRNA expression of monosaccharide transporters did not
significantly differ between newborn and adult samples, luminal fructose transporter GLUT5 protein
was absent in 0- to 4-day-old neonates, but expressed in adults. The mRNA expression of the 5 tested
monosaccharide transporters was unchanged distal from the JIA relative to proximal. Similarly, luminal
sodium-dependent glucose transporter SGLT1 and basolateral GLUT2 were expressed proximal and distal
to JIA as visualized by immunofluorescence staining. With the exception of glucose transporter GLUT1
that showed highest expression levels in colon, all investigated hexose transporters showed strongest
expression in duodenum, lower levels in ileum and lowest in colon. CONCLUSIONS: Human newborns
lack small intestinal fructose transporter GLUT5 protein expression and small intestinal atresia does not
affect the expression of hexose transporters.
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ABSTRACT
Objectives: In newborn rodents, intestinalmaturation involves delayed fructose
transporter GLUT5 expression until weaning. In jejunoileal atresia (JIA), distal
intestinal segments lack exposure to amniotic fluid-containing carbohydrates.
We assessed in human newborns, the impact of intestinal maturation and
obstruction on mucosal monosaccharide transporter expression.
Methods: Samples were obtained from 10 newborns operated for small
intestinal atresia and from 17 adults undergoing gastroduodenoscopy and/
or ileocolonoscopy. mRNA expression of the transporters SGLT1, GLUT1,
GLUT2,GLUT5, andGLUT7wasmeasured in neonate samples proximal and
distal of the atresia as well as in adult duodenum, ileum, and colon. Protein
expression and localization was assessed using immunofluorescence.
Results: Although mRNA expression of monosaccharide transporters did not
significantly differ between newborn and adult samples, luminal fructose
transporter GLUT5 protein was absent in 0- to 4-day-old neonates, but
expressed in adults. The mRNA expression of the 5 tested monosaccharide
transporters was unchanged distal from the JIA relative to proximal. Similarly,
luminal sodium-dependent glucose transporter SGLT1 and basolateral GLUT2
were expressed proximal and distal to JIA as visualized by immunofluorescence
staining. With the exception of glucose transporter GLUT1 that showed highest
expression levels in colon, all investigated hexose transporters showed strongest
expression in duodenum, lower levels in ileum and lowest in colon.
Conclusions: Human newborns lack small intestinal fructose transporter
GLUT5 protein expression and small intestinal atresia does not affect the
expression of hexose transporters.




 Small intestinal atresia prevents intestinal exposure to
amniotic fluid.
 The expression of hexose transporters in the human
newborn gut is poorly studied.
What Is New
 Fructose transporter GLUT5 mRNA but not protein is
expressed in the newborn small intestine.
 Small intestinal atresia does not seem to affect hexose
transporter expression.
 Human newborn intestine is not equipped for fruc-
tose absorption in the first days of life.
I ntestinal monosaccharide absorption involves luminal uptakeand basolateral efflux mediated by enterocyte transporter fami-
lies SGLT and GLUT (1,2). The mostly studied intestinal mono-
saccharide transporters belonging to these 2 families are SGLT1
(SLC5A1), GLUT2 (SLC2A2), and GLUT5 (SLC2A5) (3,4).
SGLT1 is a brush border membrane (BBM) glucose and galactose
symporter (5), its defect resulting in ose-galactose malabsorption
(5,6). The uniporter GLUT2 is expressed in the basolateral mem-
brane, transporting glucose, galactose, and fructose. GLUT5 exclu-
sively transports fructose across the BB (7). The transporter GLUT7
was more recently described, and is highly expressed in the small
intestine. Its substrate is not known yet (8). Glucose transporter
GLUT1 (SLC2A1), although normally hardly present in entero-
cytes, is highly expressed in cells undergoing oncogenic transfor-
mation, reflecting the increased cellular glucose metabolism (9).
Intestinal glucose uptake can be detected in human fetuses at
11 weeks of gestation and increases with further development (10).
In newborn rodents, GLUT2 and SGLT1 are already expressed at
birth, whereas GLUT5 expression is delayed until weaning is
completed (11–13). Expression of intestinal monosaccharide trans-
porters in human newborns has yet to be completely studied. The
capacity of the small intestine to absorb monosaccharides depends,
among other factors, on the abundance of monosaccharide trans-
porters (14). Lack of functional small intestine that is commonly
seen after major intestinal resection (eg, in newborns with necro-
tizing enterocolitis), leads to short bowel syndrome (15). Knowl-
edge about the longitudinal expression of nutrient transporters may
affect clinical decision-making when parts of the small intestine
need to be resected. A first aim of the present study was hence to
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assess the expression of monosaccharide transporters in their first
days after birth.
Amniotic fluid (AF), containing many nutrients, is considered
a regulatory fuel during intrauterine growth, and is swallowed by the
fetus (13,16,17). This constant swallowing is blocked in neonates
with jejuno-ileal atresia (JIA), a complete intestinal obstruction
resulting from disrupted mesenteric blood supply (18). Experimental
disruptionof amniotic fluid passage in animals led to altered intestinal
mucosa development (19) and decreased somatic growth (20). Simi-
larly, newborns with bowel resection for small intestinal atresia may
showmalabsorption and delayed growth correlatingwith the remain-
ing length of functional small bowel (21). Whether this is in part
attributed to a reduced nutrient transport capacity of the remaining
bowel distal to the atresia is not known. A second aim of the present
study was hence to assess the effect of JIA on small intestinal
monosaccharide transporter expression.
MATERIALS AND METHODS
Study Population and Sample Collection
Newborns
Newborns with jejunal or ileal atresia were included in the
present study. In patients with multiple atresias, only tissue immedi-
ately adjacent to the most proximal atresia was used for further
analysis. Patients were treated at the University Children’s Hospitals
in Basel and in Zurich. Ten (6 male and 4 female infants) newborns
were included. Thereof, 5 patients had complete jejunal and4 patients
had complete ileal atresia.Onepatient suffered from ileal stenosis and
was hence excluded from analyses proximal versus distal to atresia,
but was included in analyses of newborns versus adults (Table 1).
Age at surgery ranged from 0 to 4 days (median: 2 days), and
patients’ gestational age ranged from 34þ 3/7 to 39 weeks with 4 of
10 newborns being born preterm. Newborn’s birth weight ranged
from 2050 to 3900 g (median: 3040g). After tissue removal in the
operating room, tissue samples were either cut (for later cryosections
and immunofluorescence) or the mucosa was scraped off the submu-
cosa using the backside of a scalpel (for later RNA extraction).
Specimens where transferred into 1.5mL microcentrifuge tubes
(Eppendorf tubesâ3810X, Eppendorf AG, Hamburg, Germany),
immersed in liquid nitrogen, and stored at 808C until further
processing.
Adults
Seventeen adult patients (9 men and 8 women) were included
in the present study. Median patient’s age was 62 years (range: 41–
77 years). Patients underwent gastroduodenoscopy, combined
gastroduodenoscopy and ileocolonoscopy, or ileocolonoscopy as part
of a routinemedical checkup at theUniversity of Zurich, Switzerland,
Department of Gastroenterology. Patients younger than 18 years or
older than 80 years were excluded, as well as patients with patholo-
gies of thegastrointestinal tract.Mucosal biopsieswere obtained from
the descending/horizontal part of the duodenum (13 patients), the
terminal ileum (5 patients), and from the ascending colon (9 patients).
After removal, tissue samples were transferred to 1.5mL tubes,
immediately frozen in liquid nitrogen and stored at 808C.
Cryosections and Immunofluorescence
Fresh frozen tissue was cut into 5mm thick cryosections as
described elsewhere (22). Briefly, samples were embedded in optical
cutting temperature (OCT) compound (Medite Medizinaltechnik
AG, Switzerland), cut with a cryotome (Leica CM 1850 Cryostat,
Switzerland), transferred onto polysine slides (Thermo Fisher Scien-
tific, Waltham, Massachusetts, USA) and stored at 208C until
further processing. Before fixation, slides were allowed to thaw
for 5 minutes in a wet chamber. Thereafter, slides were fixed for
either 90 seconds inmethanol at208C(GLUT2) or for 30minutes in
3%paraformaldehyde (PFA;GLUT5andSGLT1) and thenwashed in
phosphate-buffered saline (PBS). PFA-fixated slides underwent heat-
induced epitope retrieval in sodium citrate pH 6 at 988C in a
microwave pressure cooker (HistosPRO [SW 2.0.0] Rapid Micro-
wave Histoprocessor, Milestone Srl, Italy) for 10 minutes. In order to
block unspecific binding, specimens were incubated for 30 minutes
with 2% bovine serum albumin (BSA) in PBS containing 0.04%
Triton X-100 (Sigma-Aldrich, St. Louis, Missouri, USA) before
incubation with primary antibodies. The primary antibodies used
were polyclonal rabbit anti-GLUT2, polyclonal rabbit anti-GLUT5
and polyclonal rabbit anti-SGLT1 (catalogue numbers HPA028997,
HPA005449, and HPA055106, all Sigma-Aldrich, St. Louis, Mis-
souri, USA). Antibodies were diluted 1 : 300 (GLUT2), 1 : 200
(GLUT5), and 1 : 500 (SGLT1) and incubated on specimen for 1
hour at room temperature. After incubation, slideswerewashed twice
in hypertonic PBS, additionally containing 18 g NaCl/L, and once in
normal PBS. Thereafter, specimens were incubated with an Alexa
Fluor 488-conjugated polyclonal donkey anti-rabbit IgG antibody
(catalogue #ab150061, Abcam, Cambridge, United Kingdom)
diluted 1:500 and4’,6-Diamidino-2-Phenylindole (DAPI; Invitrogen,
Carlsbad, California, USA) for 1 hour at room temperature. Slides
were washed twice in hypertonic and once in conventional PBS and
mounted with coverslips using an aqueous glycergel mounting
medium (Agilent Technologies, Santa Clara, USA).
For analysis, we used a Nikon Eclipse TE300 epifluores-
cence microscope equipped with a DS-5M Standard charge-coupled
device camera. Images were acquired via the NISElements software
(all from Nikon Instruments, Inc., Tokyo, Japan) and were merged
in Adobe Photoshop CS5. Scale bars were added using Fiji/ImageJ
(SciJava). All image acquisition and processing steps were per-
formed applying standardized conditions for each antibody, thereby
ensuring comparability.
RNA Extraction and Real-time Reverse
Transcriptase Polymerase Chain Reaction
First, frozen biopsies (adults) and frozen scraped mucosa
(newborns) were homogenized with the use of MagNa Lyser Green
Beads (Roche, Basel, Switzerland). For RNA extraction, a RNeasy
Mini Kit (Qiagen, Venlo, Netherlands) was used following the
manufacturer’s instructions. RNA quantity and quality were
assessed with a ND-1000 NanoDrop UV-spectrophotometer (Nano-
Drop Technologies, Wimington, USA) and an Agilent 2100 Bioa-
nalyzer (Agilent Technologies, Santa Clara, USA), respectively.





Age at surgery, mean [days] (range) 2 (0–4)
Gestational age, mean [weeks] (range) 37.3 (34.4–41.3)
Birth weight, mean [g] (range) 2874 (2430–3900)
Type of defect, n (%)
Atresia 9 (90)
Stenosis 1 (10)
Location of defect, n (%)
Ileum 5 (50)
Jejunum 5 (50)
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After reverse transcription of 8 ng/mL RNA with the TaqMan
Reverse Transcription Kit (Applied Biosystems, Foster City,
California, USA), we performed quantitative PCR (qPCR) for
GLUT1, GLUT2, GLUT5, GLUT7, and SGLT1, taking 8 ng of
cDNA as template. All qPCR reactions were carried out in dupli-
cates using the TaqMan Reverse Transcription Kit (Applied Bio-
systems, Foster City, California, USA) in a Prism 7700 cycler
(Applied Biosystems, Foster City, California, USA). Reactions
were carried out as duplex, using target gene primers and probes
(Microsynth, Balgach, Switzerland) and eukaryotic 18S rRNA as
endogenous control (Applied Biosystems, Foster City, California,
USA) simultaneously. Primer and probe sequences are listed in
Supplemental Digital Content 1 (http://links.lww.com/MPG/B671).
Expression levels of target mRNA relative to the housekeeping 18S
rRNA were calculated as described previously (22).
Ethics
This study was approved by the local ethics committee
(biopsies from adults: EK-1744; biopsies from newborns: KEK-
ZH-Nr. 2010-0387/EKNZ 2015-182). Written informed consent was
obtained from all patients (adult samples), respectively, from
patients’ caregivers (newborn samples).
Statistics
For graphic representation (real-time PCR data) and statisti-
cal analysis, the statistical software Graphpad Prism 5 (GraphPad
Software, San Diego, CA) was used. P values of 0.05 were
considered statistically significant. Represented bars show mean
and standard error of the mean (SEM). Statistical tests included 1-
way analysis of variance (ANOVA) with Bonferroni’s comparison
of all pairs of columns (for nonrepeated parametric data), 2-tailed
unpaired t-tests (for unpaired parametric data) and 2-tailed paired
t-tests (for paired parametric data).
RESULTS
Expression of Monosaccharide Transporter
mRNAs in Intestine of Human Adults and
Newborns
Mucosal biopsies from the duodenum, terminal ileum and
ascending colon were taken from 17 adult patients undergoing
gastroduodenoscopy and/or ileocolonoscopy, and the monosaccha-
ride transporter mRNA expression relative to 18S rRNA was
measured using real-time reverse transcriptase polymerase chain
reaction (rt-PCR). The mRNA levels of monosaccharide transpor-
ters GLUT2, GLUT5, GLUT7, and SGLT1 were highest in the
duodenum, significantly lower (2–10-fold) in ileum and even lower
in distal colon. In contrast, GLUT1 showed a significantly higher
mRNA level in colon compared with duodenum and ileum
(P  0.001), which displayed similar lower levels (Fig. 1A–E).
The mRNA expression levels of monosaccharide transpor-
ters (relative to 18S RNA) measured in terminal ileum mucosal
biopsies of adults were compared with the levels measured in
surgical specimens (mean value of proximal and distal samples)
from jejunum and ileum of human newborns. Interestingly, mRNA
levels were not significantly different for any of the tested mono-
saccharide transporters, although there was a nonsignificant trend to
higher values in newborns for GLUT1 (P¼ 0.102), GLUT2
(P¼ 0.106), and GLUT7 (P¼ 0.057) (Fig. 1F).
Surgical resection-margins proximal and distal to small
intestinal atresia were processed and monosaccharide transporter
mRNA levels measured using real-time rt-PCR. Interestingly, there
was no difference between small intestinal segments proximal and
distal to JIA (Fig. 1G).
Intestinal Monosaccharide Transporter Protein
Expression in Intestine of Human Adults and
Newborns
Immunofluorescence staining of intestinal biopsies from
duodenum, terminal ileum, and ascending colon of adults was
performed. GLUT2 staining was seen in the basolateral membrane
in duodenum (Fig. 2A, F, and K) and terminal ileum (Fig. 2B, G,
and I). GLUT5 was detected at the luminal membrane of enter-
ocytes in duodenum (Fig. 3A, F, and K) and terminal ileum
(Fig. 3B, G, and L). Similarly to GLUT5, SGLT1 apical staining
was seen in duodenum (Fig. 4A, F, and K) and ileum (Fig. 4B, G,
and L). Colonic samples did not show any staining for GLUT2,
GLUT5, or SGLT1, indicating a very low expression level or the
absence of these proteins (Figs. 2–4C, H, and M).
Immunofluorescence staining on newborn small intestinal
segments revealed a signal for GLUT2 at the basolateral membrane
of enterocytes and for SGLT1 at the luminal brush-border mem-
brane, both in the segments proximal (Figs. 2 and 4D, I, and N) and
distal (Figs. 2 and 4E, J, and O) to JIA, with no differences in
subcellular localization. Interestingly, GLUT5 was not detectable in
newborn small intestine (Fig. 3D, E, I, J, N, and O) whereas in adult
duodenum and ileum, a clear staining of the apical enterocyte
membrane was visible (Fig. 3A, B, F, G, K, and L).
DISCUSSION
Developmental Regulation of Intestinal
Monosaccharide Transport
In view of the lack of other possibilities to obtain intestinal
tissue from human newborn, the resection of JIA represents a
unique opportunity. The resected tissue from proximal to the atresia
had rather normal conditions of development. In contrast, the
mucosa from beyond the atresia has not been exposed during late
fetal life to the bolus made of swallowed amniotic fluid because of
the interruption of the intestinal continuity. Thus, differences in
intestinal mucosa development potentially because of the lack of
passage of bolus containing amniotic fluid may be investigated (see
below). We, thus, first studied the normal development of mucosal
monosaccharide transporters and compared our findings in new-
borns with results obtained in samples taken from the ileum of
adults during routine endoscopy.
We observed at the mRNA level that expression of intestinal
monosaccharide transporters GLUT1, GLUT2, GLUT5, SGLT1,
and of GLUT7 relative to the ribosomal RNA 18S, did not signifi-
cantly differ between human newborns and adults, with GLUT1/2,
and 7 expression showing a trend to be higher in newborns. This is
in contrast with rats and rabbits where GLUT5 mRNA expression is
delayed during development until the suckling and weaning period
is completed (11). Similarly, as in the present study, SGLT1 and
GLUT2 are already expressed at birth in rodents (11). A similar
developmental regulation of SGLTl, GLUT1, GLUT2, and GLUT5
mRNA expression has been observed in a previous study of human
fetuses: SGLT1 mRNAwas first detected at 17 weeks of gestational
age and reached adult levels by 19 weeks. GLUT2 mRNA was first
detected at 11 weeks (the earliest time studied) and levels increased
during pregnancy. In contrast, GLUT5 mRNA was barely detect-
able in fetal small intestine and its protein was reported to be
localized at the intercellular junctions of the developing villus (23).
In the present study, GLUT5 protein expression was, however, not
detected in neonates ages 0 to 4 days, suggesting a deferred mRNA
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translation or protein stabilization. With GLUT5 not being
expressed in the BBM, and in the absence of other still unknown
BBM fructose transporters or efficient paracellular transport, new-
borns cannot efficiently absorb fructose in their first days of life.
Fructose is not naturally present in maternal milk; however, it can
be found in low concentrations in breast milk because of the
mothers’ diet (24). Symptoms of vomiting, regurgitation, and/or
abdominal bloating, which may be seen in newborns after breast
milk intake might hence be caused by temporary dietary fructose
intolerance. The pathophysiology of fructose malabsorption is
unknown, but is likely correlated to small intestinal GLUT5
expression (25). Its prevalence correlates with age, with infants
more often being affected than older children (25,26). As dietary
fructose restrictions ameliorate symptoms in childrenwith fructose
malabsorption, avoidance of high fructose diet in early lactating
mothers might improve symptoms of breast milk intolerance
in newborns.
On the contrary, GLUT2 protein was expressed in human
newborns proximal and distal to small intestinal atresia. As in
adults, GLUT2 protein localized exclusively to the basolateral
enterocyte membrane. Also, SGLT1 showed a similar protein
expression pattern in human newborn BBM of both proximal
and distal to atresia, as in adult ileum.
In the present study, tissue samples from newborn jejunum or
ileum were compared with adult terminal ileum specimens. Thus,
differences in longitudinal transporter expression might hence have
biased our results. Additionally, whereas specimens from adults
were obtained from ileum during routine lower endoscopy, new-
born samples were collected during surgery for small intestinal
atresia and might hence be affected by the disease itself. Neverthe-
less, other indications to resect small intestine in newborns (such as,
eg, necrotizing enterocolitis or volvulus) are likely to alter the
intestinal mucosa more than small intestinal atresia. Another pos-
sible confounder in this study is the feeding state from the patients at
FIGURE 1. (A–E) mRNA expression of GLUT1, GLUT2, GLUT5, GLUT7, and SGLT1 in duodenum, terminal ileum, and ascending colon;
nonrepeated ANOVAwith Bonferroni comparison of all pairs of columns. (F andG)Monosaccharide transporter expression in adults versus newborns
(F) and in newborns proximal versus distal of JIA (G); multiple unpaired 2-tailed t-tests. (A–E) Boxplots show the median and the upper (75th







P0.001. ANOVA ¼ analysis of variance; JIA ¼ jejunoileal atresia; SEM ¼ standard error of mean.
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the sample collection time. Adult patients undergoing lower
endoscopy were made ‘‘nothing by mouth’’ the night prior endos-
copy, whereas in some newborns, an oral feeding attempt might
have been undertaken before the intestinal obstruction became
evident.
Intestinal Occlusion Does Not Affect
Monosaccharide Transporter Expression
Jejunoileal atresia likely results from a vascular event during
late pregnancy compromising mesenteric blood supply to a small
bowel segment. This hypothesis is supported by animal models with
JIA development following in utero ligation of mesenteric blood
vessels (27). Furthermore, maternal exposure to vasoconstrictive
agents during pregnancy increases the likelihood of JIA develop-
ment (18). At term, the fetus swallows around 3/4 L of amniotic
fluid per day. The amniotic fluid contains many biologically
relevant compounds, such as carbohydrates, amino acids, proteins,
peptides, lipids, and hormones that have been suggested to facilitate
small intestinal and fetal growth (20,28). This important role of
luminal amniotic fluid components has indeed been experimentally
verified in animals in which proximal intestinal obstruction was
shown to result in a decrease in intestinal villus height and somatic
growth (20,29–31). In the presented study, small intestinal atresia
surprisingly had no significant effect on the expression of GLUT1,
GLUT2, GLUT5, GLUT7, or SGLT1 mRNA. Furthermore, quali-
tative analysis of GLUT2 and SGLT1 IF staining showed similar
patterns proximal and distal to the intestinal atresia. These findings,
however, confirm previous results showing unimpaired GLUT2
expression proximal and distal to JIA (32), and add information on
the expression of monosaccharide transporters GLUT5 and SGLT1,
which had not been studied previously.
FIGURE 2. Immunofluorescence staining of GLUT2 (green). Cellular DNA (A–T; DAPI; blue) is shown to display the nuclei. Tissue specimens are
derived from adult duodenum (A, F, and K), terminal ileum (B, G, and L), and ascending colon (C, H, andM) as well as from newborns proximal (D,
I, and N) and distal (E, J, and O) to JIA. Negative controls without a primary antibody against GLUT2 are shown from adults in duodenum (P),
terminal ileum (Q), and ascending colon (R), as well as from newborns proximal (S) and distal to atresia (T). Scale bars¼100mm. JIA¼ jejunoileal
atresia.
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Monosaccharide Transporter Expression Along
the Adult Human Intestine
Information about the longitudinal distribution of mono-
saccharide transporters in the human intestine are sparse
and incomplete in the literature (23). Unlike amino acid trans-
porters, showing variable transporter expression alongside the
digestive tract of humans (22) and rodents (33), the transporters
GLUT2, GLUT5, GLUT7, and SGLT1 uniformly exhibited a
decreasing mRNA expression pattern from proximal (duodenum)
to distal (colon) in the present study. This data resembles the
mRNA expression pattern previously observed in mice (34), rats
(35), and also in humans as published in the public domain on
website ‘‘The Human Protein Atlas’’, where GLUT2 and GLUT7
were expressed at the RNA and at the protein level in duodenum
and small intestine, but not in colon. Similarly, GLUT5 and
SGLT1 showed much higher RNA and protein expression levels
in duodenum and small intestine than in colon (https://www.
proteinatlas.org).
Interestingly, the small intestine lacks the expression of high-
capacity low-affinity transporter SGLT2 (SLC5A2) to complement
the expression of SGLT1, a high-affinity low-capacity transporter,
as it is observed in the kidney. In kidney proximal tubule, SGLT2 is
expressed in the early convoluted segments S1 and S2 where the
bulk of glucose reabsorption takes place. SGLT1 is, therefore,
primarily expressed in the more distal proximal tube (straight
segment S3) and enables the uptake of remaining luminal glucose
(36,37). Contrary to kidneys, the low-affinity transporter SGLT2 is
absent in human intestine (38).
GLUT1 is highly expressed in different cell types, in many
tumors (39–43), and in various fetal tissues including lungs and
intestine, likely reflecting increased glucose metabolism because of
cell proliferation and maturation (23,44). Our results showed higher
GLUT1 mRNA expression in the large intestine when compared
FIGURE 3. Immunofluorescence staining of GLUT5 (green). Nuclear DNA (A–T; DAPI; blue) is shown to display the nuclei. Tissue specimens are
derived from adult duodenum (A, F, and K), terminal ileum (B, G, and L), and ascending colon (C, H, andM) as well as from newborns proximal (D,
I, and N) and distal (E, J, and O) to JIA. Negative controls without a primary antibody against GLUT5 are shown from adults in duodenum (P),
terminal ileum (Q), and ascending colon (R), as well as from newborns proximal (S) and distal to atresia (T). Scale bars¼100mm. JIA¼ jejunoileal
atresia.
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with small intestine (duodenum and ileum). This data, reflecting
results previously observed in mice (2) and in humans (https://
www.proteinatlas.org), might indicate a role of GLUT1 to provide
energy to colonocytes, instead of it being part of the intestinal
nutrient absorption machinery. Under normal conditions, most of
the glucose is absorbed in the small intestine with only limited
amounts reaching the colon (2,45,46). Correspondingly, the trans-
porters involved in transcellular glucose absorption are not
expressed in colon, in particular, also not the basolateral uniporter
GLUT2 that can function as both glucose efflux and uptake
pathway. Thus, the higher GLUT1 expression in the colon might
be reflective of the need for another basolateral glucose transporter
in this part of the GI to mediate the glucose uptake from the
bloodstream as an energy source for colonic enterocytes (2).
GLUT7 was shown to be expressed in rodents’ small intes-
tine and suggested to localize to the apical membrane (47). Initially
described as a fructose and glucose transporter (47), it was recently
characterized as an orphan transporter (8). Our data suggest that as
for adults, GLUT7 is expressed at the RNA level in human new-
borns and its expression was not modified by the presence of JIA.
Unfortunately, because of the lack of specific antibodies, we could
not analyze the localization of GLUT1 or GLUT7 in the
human intestine.
Taken together, this study shows that in the newborn human
gut, the fructose transporter GLUT5 is not expressed at the protein
level, whereas its mRNA is expressed as in adults. In contrast, the
mRNAs of transporters GLUT1, GLUT2, GLUT7, and SGLT1 and
also the transport proteins GLUT2 and SGLT1 are shown to be
expressed at comparable levels in newborn and adult small intes-
tine. In addition, gene and protein expression of the assessed
monosaccharide transporters was shown not to be affected by in
utero small intestinal obstruction (JIA). Finally, with the exception
of GLUT1 that is the highest expressed in colon, all other mono-
saccharide transporters assessed in this study are involved in the
FIGURE 4. Immunofluorescence staining of SGLT1 (green). Cellular DNA (A–T; DAPI; blue) is shown to display the nuclei. Tissue specimens are
derived from adult duodenum (A, F, and K), terminal ileum (B, G, and L), and ascending colon (C, H, andM) as well as from newborns proximal (D,
I, and N) and distal (E, J, and O) to JIA. Negative controls without a primary antibody against SGLT1 are shown from adults in duodenum (P),
terminal ileum (Q), and ascending colon (R), as well as from newborns proximal (S) and distal to atresia (T). Scale bars¼100mm. JIA¼ jejunoileal
atresia.
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absorption of luminal carbohydrates and display decreasing expres-
sion levels from proximal to distal along the intestine.
It remains unclear at what age GLUT5 protein is expressed in
human enterocytes. It would hence be valuable to assess intestinal
GLUT5 expression at different development stages, as well as
whether its expression may be stimulated by diet containing fruc-
tose. Moreover, a comparison of the transcriptomes proximal versus
distal to small intestinal atresia would be of interest to assess more
broadly the effect of temporary amniotic fluid exclusion on intesti-
nal gene expression.
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